
Lipostabil is a drug based on phosphatidylcoline and deoxycholate, evolved from the initial intravenous use of those drug formulations to treat blood disorders.
While the safety of lipodissolve injections has yet to be proven in a prospective, placebo-controlled, double-blind clinical study, retrospective studies suggest that this practice does not present significant medical risk.
Lipostabil is injected directly into the subcutaneous fat through multiple microinjections administered over multiple treatment sessions. The desired end result is the removal of localized fat deposits.